{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T23:30:40Z","timestamp":1793403040135,"version":"4.5.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Obes"],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Obesity is associated with adverse alterations in lipoprotein profiles and increased cardiometabolic risk, yet standard clinical lipid measures provide limited resolution of the underlying lipoprotein structure. Here, we perform a population-level characterisation of the impact of obesity on the high-resolution blood lipoprotein subfraction profile.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Lipoprotein profiles were investigated in an Australian cohort (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20091806) stratified by Body Mass Index (BMI) (healthy weight, overweight, obese). The composition and particle number of lipoproteins and their subfractions were quantified (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009112 parameters) using\n                      <jats:sup>1<\/jats:sup>\n                      H NMR spectroscopy. Associations between BMI, lipoprotein subfractions, and particle number ratios were evaluated. Key BMI-associated ratios were validated in a second Australian cohort (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20091313)\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Participants with obesity had significantly higher particle concentrations of VLDL and IDL and lower HDLs, while total LDL concentration was similar between the BMI categories. Notably, obesity was associated with a marked redistribution of LDL subfractions, with a shift from larger, buoyant LDL1\u20133 particles to smaller, dense LDL4\u20136 particles, accompanied by a similar shift in HDL subfractions, with proportionally lower concentrations of HDL1\u20133 particles in the high BMI group. An inverse association between BMI was found for two LDL particle number ratios (LDL1\u20133:LDL4\u20136 and LDL2:LDL5) and one HDL ratio (HDL1:HDL4), which demonstrated good discriminatory power for obesity status (AUROCs 0.70\u20130.74).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The pattern of lipoprotein subfraction redistribution in participants with obesity was consistent across cohorts. These subfractional changes offer enhanced resolution compared with conventional lipid and lipoprotein measures and may contribute to improved cardiovascular risk stratification in individuals with obesity.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1038\/s41366-026-02172-6","type":"journal-article","created":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T14:42:31Z","timestamp":1786632151000},"page":"2195-2204","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["High resolution lipoprotein subfraction profiling identifies obesity associated distributional changes in LDL and HDL subfractions and particle ratios"],"prefix":"10.1038","volume":"50","author":[{"given":"Novia","family":"Minaee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reika","family":"Masuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Nitschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Drew","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennie","family":"Hui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6704-4815","authenticated-orcid":false,"given":"Michael L.","family":"Hunter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leon","family":"Flicker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graeme J.","family":"Hankey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8689-6199","authenticated-orcid":false,"given":"Osvaldo P.","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7658-5197","authenticated-orcid":false,"given":"Dick C.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald F.","family":"Watts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Saeed","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huda M.","family":"Alkreathy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoheir Abdullah","family":"Dhamanouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hartmut","family":"Sch\u00e4fer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manfred","family":"Spraul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Cannet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P.","family":"Beilby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bu B.","family":"Yeap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar","family":"Millet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3416-2572","authenticated-orcid":false,"given":"Julien","family":"Wist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8123-8349","authenticated-orcid":false,"given":"Jeremy K.","family":"Nicholson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9193-0462","authenticated-orcid":false,"given":"Samantha","family":"Lodge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0556-8389","authenticated-orcid":false,"given":"Elaine","family":"Holmes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,13]]},"reference":[{"key":"2172_CR1","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.3390\/nu5041218","volume":"5","author":"B Klop","year":"2013","unstructured":"Klop B, Elte JWF, Cabezas MC. Dyslipidaemia in obesity: mechanisms and potential targets. Nutrients. 2013;5:1218\u201340.","journal-title":"Nutrients"},{"key":"2172_CR2","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1021\/acs.jproteome.3c00717","volume":"23","author":"MS Ahmad","year":"2024","unstructured":"Ahmad MS, Minaee N, Serrano-Contreras JI, Kaluarachchi M, Shen EYL, Boulange C. et al. Exploring the Interactions between Obesity and Diabetes: Implications for Understanding Metabolic Dysregulation in a Saudi Arabian Adult Population. J Proteome Res. 2024;23:809\u201321.","journal-title":"J Proteome Res"},{"key":"2172_CR3","doi-asserted-by":"publisher","first-page":"e984","DOI":"10.1161\/CIR.0000000000000973","volume":"143","author":"TM Powell-Wiley","year":"2021","unstructured":"Powell-Wiley TM, Poirer P, Burke LE, Despres JP, Gordon-Larsen P, Lavie CJ, et al. Obesity and Cardiovascular Disease: A Scientific Statement from the American Heart Association. Circulation. 2021;143:e984\u2013e1010.","journal-title":"Circulation"},{"key":"2172_CR4","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/nrcardio.2013.140","volume":"10","author":"GF Watts","year":"2013","unstructured":"Watts GF, Ooi EMM, Chan DC. Demystifying the management of hypertriglyceridemia. Nat Rev Cardiol. 2013;10:648\u201361.","journal-title":"Nat Rev Cardiol"},{"key":"2172_CR5","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1161\/CIRCULATIONAHA.113.005757","volume":"129","author":"ATH Frank","year":"2014","unstructured":"Frank ATH, Zhao B, Jose PO, Azar KMJ, Fortmann SP, Palaniappan LP. Racial\/ethnic differences in dyslipidaemia patterns. Circulation. 2014;129:570\u20139.","journal-title":"Circulation"},{"key":"2172_CR6","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s13679-023-00518-z","volume":"12","author":"J Vekic","year":"2023","unstructured":"Vekic J, Stefanovic A, Zeljkovic A. Obesity and Dyslipidemia: A Review of Current Evidence. Curr Obes Rep. 2023;12:207\u201322.","journal-title":"Curr Obes Rep"},{"key":"2172_CR7","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.jacl.2021.09.046","volume":"15","author":"PWF Wilson","year":"2021","unstructured":"Wilson PWF, Jacobson TA, Martin SS, Jackson EJ, Le NA, Davidson MH, et al. Lipid measurements in the management of cardiovascular diseases: Practical recommendations a scientific statement from the national lipid association writing group. J Clin Lipido. 2021;15:629\u201348.","journal-title":"J Clin Lipido"},{"key":"2172_CR8","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/S0022-2275(20)30176-0","volume":"43","author":"A Sawle","year":"2002","unstructured":"Sawle A, Higgins MK, Olivant MP, Higgins JA. A rapid single-step centrifugation method for determination of HDL, LDL and VLDL cholesterol, and TG, and identification of predominant LDL subclass. J Lipid Res. 2002;43:335\u201343.","journal-title":"J Lipid Res"},{"key":"2172_CR9","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.ecl.2022.02.009","volume":"51","author":"D Lucero","year":"2022","unstructured":"Lucero D, Wolska A, Aligabi Z, Turecamo S, Remaley AT. Lipoprotein Assessment in the twenty-first Century. Endocrinol Metab Clin North Am. 2022;51:459\u201381.","journal-title":"Endocrinol Metab Clin North Am"},{"key":"2172_CR10","doi-asserted-by":"publisher","first-page":"247.","DOI":"10.1186\/s12944-020-01424-2","volume":"19","author":"E Garcia","year":"2020","unstructured":"Garcia E, Bennett DW, Connelly MA, Jeyarajah EJ, Warf FC, Shalaurova I. et al. The extended lipid panel assay: a clinically-deployed high-throughput nuclear magnetic resonance method for the simultaneous measurement of lipids and Apolipoprotein B. Lipids Health Dis. 2020;19:247.","journal-title":"Lipids Health Dis"},{"key":"2172_CR11","doi-asserted-by":"publisher","first-page":"11962","DOI":"10.1021\/acs.analchem.8b02412","volume":"90","author":"B Jimenez","year":"2018","unstructured":"Jimenez B, Holmes E, Heude C, Tolson RF, Harvey N, Lodge S, et al. Quantitative Lipoprotein Subclass Analysis in Human Serum and Plasma by 1H NMR Spectroscopy in a Multilaboratory Trial. Anal Chem. 2018;90:11962\u201371.","journal-title":"Anal Chem"},{"key":"2172_CR12","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1021\/acs.jproteome.0c00815","volume":"20","author":"S Lodge","year":"2021","unstructured":"Lodge S, Nitschke P, Loo RL, Kimhofer T, Bong SH, Richards T, et al. Low Volume in Vitro Diagnostic Proton NMR Spectroscopy of Human Blood Plasma for Lipoprotein and Metabolite Analysis: Application to SARS-CoV-2 Biomarkers. J Proteome Res. 2021;20:1415\u201323.","journal-title":"J Proteome Res"},{"key":"2172_CR13","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1152\/physiolgenomics.00072.2023","volume":"56","author":"AF Ahmad","year":"2024","unstructured":"Ahmad AF, Caparros-Martin JA, Gray N, Lodge S, Wist J, Lee S, et al. Gut microbiota and metabolomic profiles in patients with chronic stable angina and acute coronary syndrome. Physiol Genom. 2024;56:48\u201364.","journal-title":"Physiol Genom"},{"key":"2172_CR14","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1093\/ibd\/izad154","volume":"30","author":"L Aldars-Garcia","year":"2024","unstructured":"Aldars-Garcia L, Gil-Redondo R, Embade N, Rietsra S, Rivero M, Guiterrez A, et al. Serum and Urine Metabolomic Profiling of Newly Diagnosed Treatment-Na\u00efve Inflammatory Bowel Disease Patients. Inflamm Bowel Dis. 2024;30:167\u201383.","journal-title":"Inflamm Bowel Dis"},{"key":"2172_CR15","doi-asserted-by":"publisher","first-page":"11614","DOI":"10.3390\/ijms241411614","volume":"24","author":"S Lodge","year":"2023","unstructured":"Lodge S, Lawler NG, Gray N, Masuda R, Nitschke P, Whiley L, et al. Integrative Plasma Metabolic and Lipidomic Modelling of SARS-CoV-2 Infection in Relation to Clinical Severity and Early Mortality Prediction. Int J Mol Sci. 2023;24:11614.","journal-title":"Int J Mol Sci"},{"key":"2172_CR16","doi-asserted-by":"publisher","first-page":"829","DOI":"10.3390\/biomedicines10040829","volume":"10","author":"H Superko","year":"2022","unstructured":"Superko H, Garrett B. Small Dense LDL: Scientific Background, Clinical Relevance, and Recent Evidence Still a Risk Even with \u2018Normal\u2019 LDL-C Levels. Biomedicines. 2022;10:829.","journal-title":"Biomedicines"},{"key":"2172_CR17","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1124\/pr.58.3.1","volume":"58","author":"A Kontush","year":"2006","unstructured":"Kontush A, Chapman MJ. Functionally Defective High-Density Lipoprotein: A New Therapeutic Target at the Crossroads of Dyslipidaemia, Inflammation, and Atherosclerosis. Pharmacol Rev. 2006;58:342\u201374.","journal-title":"Pharmacol Rev"},{"key":"2172_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-13-936","volume":"13","author":"A James","year":"2013","unstructured":"James A, Hunter M, Straker L, Beilby J, Bucks R, Davis T, et al. Rationale, design and methods for a community-based study of clustering and cumulative effects of chronic disease processes and their effects on ageing: the Busselton healthy ageing study. BMC Public Health. 2013;13:936.","journal-title":"BMC Public Health"},{"key":"2172_CR19","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1093\/ije\/dyn041","volume":"38","author":"PE Norman","year":"2009","unstructured":"Norman PE, Flicker L, Almeida OP, Hankey GJ, Hyde Z, Jamrozik K. Cohort Profile: The Health In Men Study (HIMS). Int J Epidemiol. 2009;38:48\u201352.","journal-title":"Int J Epidemiol"},{"key":"2172_CR20","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.jprot.2014.04.030","volume":"106","author":"A von Zychlinski","year":"2014","unstructured":"von Zychlinski A, Williams M, McCormick S, Kleffmann T. Absolute quantification of apolipoproteins and associated proteins on human plasma lipoproteins. J Proteom. 2014;106:181\u201390.","journal-title":"J Proteom"},{"key":"2172_CR21","doi-asserted-by":"publisher","first-page":"10621","DOI":"10.1016\/j.ebiom.2025.106021","volume":"122","author":"R Conde","year":"2025","unstructured":"Conde R, Gil-Redondo R, Bizkarguenaga M, Lodge S, Nitschke P, de Diego A, et al. Age- and sex- specific lipoprotein profiles in general and cardiometabolic population cohorts. EBioMedicine. 2025;122:10621.","journal-title":"EBioMedicine"},{"key":"2172_CR22","doi-asserted-by":"publisher","first-page":"4791","DOI":"10.1093\/eurheartj\/ehab551","volume":"42","author":"HN Ginsberg","year":"2021","unstructured":"Ginsberg HN, Packard CJ, Chapman MJ, Boren J, Aguilar-Salinas CA, Averna M, et al. Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies \u2013 a consensus statement from the European Atherosclerosis Society. Eur Heart J. 2021;42:4791\u2013806.","journal-title":"Eur Heart J"},{"key":"2172_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-015-0034-1","volume":"14","author":"S Kulanuwat","year":"2015","unstructured":"Kulanuwat S, Tungtrongchitr R, Billington D, Davies IG. Prevalence of plasma small dense LDL is increased in obesity in a Thai population. Lipids Health Dis. 2015;14:30.","journal-title":"Lipids Health Dis"},{"key":"2172_CR24","doi-asserted-by":"publisher","first-page":"517","DOI":"10.4093\/dmj.2022.0198","volume":"46","author":"K Kim","year":"2022","unstructured":"Kim K, Ginsberg HN, Choi SH. New, Novel Lipid-Lowering Agents for Reducing Cardiovascular Risk: Beyond Statins. Diab Metab J. 2022;46:517\u201332.","journal-title":"Diab Metab J"},{"key":"2172_CR25","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s13098-025-01644-5","volume":"17","author":"EG Moraes","year":"2025","unstructured":"Moraes EG, Generoso G, Bensenor IM, Santo RD, Santos IS, Goulart AC, et al. Association of obesity and LDL subfractions evaluated by body mass index, waist circumference, and diabetes status: the ELSA-Brasil study. Diabetol Metab Syndr. 2025;17:83.","journal-title":"Diabetol Metab Syndr"},{"key":"2172_CR26","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1038\/ijo.2008.11","volume":"32","author":"A Romero-Corral","year":"2008","unstructured":"Romero-Corral A, Somers VK, Sierra Johnson J, Thomas RJ, Collazo-Clavell ML, Korinek J, et al. Accuracy of body mass index in diagnosing obesity in the adult general population. Int J Obes. 2008;32:959\u201366.","journal-title":"Int J Obes"},{"key":"2172_CR27","doi-asserted-by":"publisher","first-page":"2670","DOI":"10.1111\/dom.13415","volume":"20","author":"J Ferrieres","year":"2018","unstructured":"Ferrieres J, Lautsch D, Gitt AK, Ferrari GD, Toplack H, Elisaf M, et al. Body mass index impacts the choice of lipid-lowering treatment with no correlation to blood cholesterol - Findings from 52916 patients in the Dyslipidemia International Study (DYSIS). Diab Obes Metab. 2018;20:2670\u20134.","journal-title":"Diab Obes Metab"},{"key":"2172_CR28","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/0021-9150(90)90131-2","volume":"83","author":"BA Griffin","year":"1990","unstructured":"Griffin BA, Caslake MJ, Yip B, Tait GW, Packard CJ, Shepherd J. Rapid isolation of low density lipoprotein (LDL) subfractions from plasma by density gradient ultracentrifugation. Atherosclerosis. 1990;83:59\u201367.","journal-title":"Atherosclerosis"},{"key":"2172_CR29","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.atherosclerosis.2015.07.040","volume":"242","author":"CM Phillips","year":"2015","unstructured":"Phillips CM, Perry IJ. Lipoprotein particle subclass profiles among metabolically healthy and unhealthy obese and non-obese adults: does size matter?. Atherosclerosis. 2015;242:399\u2013406.","journal-title":"Atherosclerosis"},{"key":"2172_CR30","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1093\/oxfordjournals.qjmed.a068888","volume":"87","author":"I Rajman","year":"1994","unstructured":"Rajman I, Maxwell S, Kendall M. Particle size: the key to the atherogenic lipoprotein?. QJM. 1994;87:709\u201320.","journal-title":"QJM"},{"key":"2172_CR31","doi-asserted-by":"publisher","first-page":"172","DOI":"10.2337\/diabetes.52.1.172","volume":"52","author":"DJ Nieves","year":"2003","unstructured":"Nieves DJ, Cnop M, Retzlaff B, Walden CE, Brunzell JD, Knopp RH, et al. The atherogenic lipoprotein profile associated with obesity and insulin resistance is largely attributable to intra-abdominal fat. Diabetes. 2003;52:172\u20139.","journal-title":"Diabetes"},{"key":"2172_CR32","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1016\/0026-0495(95)90134-5","volume":"44","author":"M Halle","year":"1995","unstructured":"Halle M, Berg A, Frey I, Konig D, Keul J, Baumstark MW. Relationship between obesity and concentration and composition of low-density lipoprotein subfractions in normoinsulinemic men. Metabolism. 1995;44:1384\u201390.","journal-title":"Metabolism"},{"key":"2172_CR33","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/S0026-0495(99)90064-1","volume":"48","author":"M Halle","year":"1999","unstructured":"Halle M, Berg A, Garwers U, Baumstark MW, Knisel W, Grathwohl D, et al. Influence of 4 weeks\u2019 intervention by exercise and diet on low-density lipoprotein subfractions in obese men with type 2 diabetes. Metabolism. 1999;48:641\u20134.","journal-title":"Metabolism"},{"key":"2172_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2022.155346","volume":"138","author":"AM Angelidi","year":"2023","unstructured":"Angelidi AM, Kokkinos A, Sanoudou D, Connelly MA, Alexandrou A, Mingrone G, et al. Early metabolomic, lipid and lipoprotein changes in response to medical and surgical therapeutic approaches to obesity. Metabolism. 2023;138:155346.","journal-title":"Metabolism"},{"key":"2172_CR35","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1001\/jamacardio.2019.3780","volume":"4","author":"AD Sniderman","year":"2019","unstructured":"Sniderman AD, Thanassoulis G, Glavinovic T, Navar AM, Pencina M, Catapano A, et al. Apolipoprotein B particles and cardiovascular disease: a narrative review. JAMA Cardiol. 2019;4:1287\u201395.","journal-title":"JAMA Cardiol"},{"key":"2172_CR36","doi-asserted-by":"publisher","unstructured":"Morze J, Melloni GEM, Wittenbecher C, Ala-Korpela M, Rynkiewicz A, Guasch-Ferre M, et al. Apo-B containing lipoproteins: count, type, size and risk of coronary artery disease. Eur Heart J. 2025;ehaf207. https:\/\/doi.org\/10.1093\/eurheartj\/ehaf207.","DOI":"10.1093\/eurheartj\/ehaf207"},{"key":"2172_CR37","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.cca.2012.09.010","volume":"414","author":"S Hirayama","year":"2012","unstructured":"Hirayama S, Miida T. Small dense LDL: An emerging risk factor for cardiovascular disease. Clin Chim Acta. 2012;414:215\u201324.","journal-title":"Clin Chim Acta"},{"key":"2172_CR38","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1194\/jlr.D700044-JLR200","volume":"49","author":"MS Yee","year":"2008","unstructured":"Yee MS, Pavitt DV, Tan T, Venkatesan S, Godsland IF, Richmond W, et al. Lipoprotein separation in a novel iodixanol density gradient, form composition, density, and phenotype analysis. J Lipid Res. 2008;49:1364\u201371.","journal-title":"J Lipid Res"},{"key":"2172_CR39","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.cca.2008.05.008","volume":"395","author":"M Okazaki","year":"2008","unstructured":"Okazaki M, Usui S, Nakamura M, Yamashita S. Evaluation of an HPLC method for LDL-cholesterol determination in patients with various lipoprotein abnormalities in comparison with beta-quantification. Clin Chim Acta. 2008;395:62\u201367.","journal-title":"Clin Chim Acta"},{"key":"2172_CR40","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1161\/CIRCRESAHA.116.309506","volume":"119","author":"S Fazio","year":"2016","unstructured":"Fazio S, Pamir N. HDL particle size and functional heterogeneity. Circ Res. 2016;119:6.","journal-title":"Circ Res"},{"key":"2172_CR41","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.3390\/nu16101525","volume":"16","author":"D Sergi","year":"2024","unstructured":"Sergi D, Sanz JM, Trentini A, Bonaccorsi G, Angelini S, Castaldo F, et al. HDL-cholesterol subfraction dimensional distribution is associated with cardiovascular risk and is predicted by visceral adiposity and dietary lipid intake in women. Nutrients. 2024;16:1525.","journal-title":"Nutrients"},{"key":"2172_CR42","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1016\/j.numecd.2021.01.025","volume":"31","author":"D Montero","year":"2021","unstructured":"Montero D, Dutheil F, Walther G, Perez-Martin A, Soto-Esclapez L, Vinet A, et al. Changes in the profile of circulating HDL subfractions in severe obese adolescents following a weight reduction program. Nutr Metab Cardiovasc Dis. 2021;31:1586\u201393.","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"2172_CR43","doi-asserted-by":"publisher","unstructured":"Lodge S, Masuda R, Nitschke P, Beilby JP, Hui J, Hunter M, et al. NMR spectroscopy derived plasma biomarkers of inflammation in human populations: Influences of age, sex and adiposity. PLOS One. 2025. https:\/\/doi.org\/10.1371\/journal.pone.0311975.","DOI":"10.1371\/journal.pone.0311975"},{"key":"2172_CR44","doi-asserted-by":"publisher","first-page":"2875","DOI":"10.1038\/oby.2007.342","volume":"15","author":"S Rashid","year":"2007","unstructured":"Rashid S, Genest J. Effect of obesity on high-density lipoprotein metabolism. Obesity. 2007;15:2875\u201388.","journal-title":"Obesity"},{"key":"2172_CR45","doi-asserted-by":"publisher","first-page":"218","DOI":"10.3389\/fphar.2015.00218","volume":"6","author":"A Kontush","year":"2015","unstructured":"Kontush A. HDL particle number and size as predictors of cardiovascular disease. Front Pharm. 2015;6:218.","journal-title":"Front Pharm"},{"key":"2172_CR46","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1097\/MOL.0b013e3282364a17","volume":"18","author":"BJ Ansell","year":"2007","unstructured":"Ansell BJ, Fonarow GC, Fogelman AM. The paradox of dysfunctional high-density lipoprotein. Curr Opin Lipido. 2007;18:427\u201334.","journal-title":"Curr Opin Lipido"},{"key":"2172_CR47","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1161\/CIRCULATIONAHA.113.005873","volume":"129","author":"S Mora","year":"2014","unstructured":"Mora S, Buring JE, Ridker PM. Discordance of low-density lipoprotein (LDL) cholesterol with alternative LDL-related measures and future coronary events. Circulation. 2014;129:553\u201361.","journal-title":"Circulation"},{"key":"2172_CR48","doi-asserted-by":"publisher","first-page":"6066","DOI":"10.2174\/0929867328666210208182326","volume":"28","author":"S Ganjali","year":"2021","unstructured":"Ganjali S, Watts GF, Benach M, Reiner Z, Nachtigal P, Sahebkar A. The yin and yang of High-density lipoprotein and atherosclerotic cardiovascular disease: Focusing on functionality and cholesterol efflux to reframe the HDL hypothesis. Curr Med Chem. 2021;28:6066\u201381.","journal-title":"Curr Med Chem"},{"key":"2172_CR49","doi-asserted-by":"publisher","first-page":"1452869","DOI":"10.3389\/fcvm.2024.1452869","volume":"11","author":"A Wolska","year":"2024","unstructured":"Wolska A, Sampson M, Zubiran R, Meeusen JW, Donato LJ, Jaffe AS, et al. An equation for estimating low-density lipoprotein-triglyceride content and its use for cardiovascular disease risk stratification. Front Cardiovasc Med. 2024;11:1452869.","journal-title":"Front Cardiovasc Med"},{"key":"2172_CR50","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1373\/clinchem.2018.287037","volume":"64","author":"MR Langlois","year":"2018","unstructured":"Langlois MR, Chapman MJ, Cobbaert C, Mora S, Remaley AT, Ros E, et al. Quantifying Atherogenic Lipoproteins: Current and Future Challenges in the Era of Personalized Medicine and Very Low Concentrations of LDL Cholesterol. A Consensus Statement from EAS and EFLM. Clin Chem. 2018;64:1006\u201333.","journal-title":"Clin Chem"},{"key":"2172_CR51","doi-asserted-by":"publisher","first-page":"6399","DOI":"10.1021\/acs.analchem.4c04660","volume":"97","author":"J Wist","year":"2025","unstructured":"Wist J, Nitschke P, Conde R, de Diego A, Bizkarguenaga M, Lodge S, et al. Benchtop Proton NMR Spectroscopy for High-Throughput Lipoprotein Quantification in Human Serum and Plasma. Anal Chem. 2025;97:6399\u2013409.","journal-title":"Anal Chem"},{"key":"2172_CR52","doi-asserted-by":"publisher","first-page":"4213","DOI":"10.1039\/D2AN01097F","volume":"147","author":"P Nitschke","year":"2022","unstructured":"Nitschke P, Lodge S, Hall D, Schafer H, Spraul M, Embade N, et al. Direct Low Field J-edited Diffusional Proton NMR Spectroscopic Measurement of COVID-19 Inflammatory Biomarkers in Human Serum. Analyst. 2022;147:4213\u201321.","journal-title":"Analyst"},{"key":"2172_CR53","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.jacl.2022.02.007","volume":"16","author":"RM Krauss","year":"2022","unstructured":"Krauss RM, Remaley AT, Chapman MJ. Concerns regarding NMR lipoprotein analyses performed on the Nightingale health platform \u2013 Focus on LDL subclasses. J Clin Lipido. 2022;16:250\u20132.","journal-title":"J Clin Lipido"}],"container-title":["International Journal of Obesity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41366-026-02172-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41366-026-02172-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41366-026-02172-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T23:01:03Z","timestamp":1793401263000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41366-026-02172-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,13]]},"references-count":53,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["2172"],"URL":"https:\/\/doi.org\/10.1038\/s41366-026-02172-6","relation":{},"ISSN":["0307-0565","1476-5497"],"issn-type":[{"value":"0307-0565","type":"print"},{"value":"1476-5497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,13]]},"assertion":[{"value":"6 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"This study was approved by Murdoch University Ethics Committee (2020\/132). Collection of the Australian population cohort was approved by The University of Western Australia\u2019s Human Research Ethics Committee (2021\/ET000260). The University of Western Australia\u2019s Human Research Ethics Committee approved the metabolomic analysis of the validation cohort (2022\/ET000199) with reciprocal ethics acquired at Murdoch University (2022\/009). All participants provided informed written consent.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Ethics"}}]}}